The Food and Drug Administration's approval Thursday of the AIDS drug Fuzeon marks the end of a 10-year odyssey for Trimeris, the drug's developer, and a coming of age for the Triangle's biotechnology industry.
»newsobserver.com/news/story/2328···63c.html